blog

We’re very pleased to congratulate F1000Prime Section Head James Allison on being awarded the Breakthrough Prize in Life Sciences in 2014.

 

This annual prize is awarded by the Breakthrough Prize in Life Sciences Foundation, a not-for-profit organisation dedicated to “advancing breakthrough research, celebrating scientists and generating excitement about the pursuit of science as a career”.

Professor Allison joined F1000Prime back in 2001 as head of the Immunomodulation Section of the Immunology Faculty and receives this prestigious award for his work on the discovery of T cell checkpoint blockade as an effective cancer therapy.

Cancer Immunotherapy is an area of research of considerable and growing interest, and in 2013 was selected as Science’s “Breakthrough of the Year”. Professor Allison’s work in this area has also earned him this year’s Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research (NFCR), specifically for the successful development of immune checkpoint therapy and the first Food and Drug Administration (FDA)-approved drug for the treatment of metastatic melanoma.

Further details on the Breakthrough Prize in Life Sciences, as well as all the awardees of 2014, can be found here. The full press release for the 2014 Szent-Györgyi Prize for Progress in Cancer Research can be read on the NFCR’s website.

Our congratulations again!